ProfileGDS4718 / 1554102_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 59% 64% 57% 58% 58% 68% 71% 60% 63% 62% 59% 56% 70% 80% 69% 60% 65% 71% 66% 57% 64% 63% 62% 63% 61% 71% 64% 75% 57% 70% 65% 74% 58% 63% 83% 81% 66% 61% 62% 63% 63% 74% 63% 79% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.0637959
GSM549102patient 115, normal, homogenized [OPG study]6.4420764
GSM549104patient 119, normal, homogenized [OPG study]5.9489357
GSM549108patient 138, normal, homogenized [OPG study]6.0252358
GSM549119patient 077, normal, homogenized [OPG study]6.0242458
GSM549133patient 032, cancer, homogenized [OPG study]6.747168
GSM549139patient 042, cancer, homogenized [OPG study]6.9958871
GSM549099patient 107, normal, homogenized [OPG study]6.0997460
GSM549109patient 139, normal, homogenized [OPG study]6.3596563
GSM549110patient 046, normal, homogenized [OPG study]6.2573962
GSM549114patient 063, normal, homogenized [OPG study]6.0246259
GSM549122patient 082, normal, homogenized [OPG study]5.8839656
GSM549134patient 033, cancer, homogenized [OPG study]6.9136970
GSM549136patient 036, cancer, homogenized [OPG study]7.9585180
GSM549140patient 044, cancer, homogenized [OPG study]6.8250569
GSM549111patient 047, normal, homogenized [OPG study]6.0994160
GSM549113patient 057, normal, homogenized [OPG study]6.4541165
GSM549132patient 031, cancer, homogenized [OPG study]6.9673671
GSM549137patient 038, cancer, homogenized [OPG study]6.5909766
GSM549142patient 047, cancer, homogenized [OPG study]6.0551157
GSM549100patient 110, normal, homogenized [OPG study]6.3836164
GSM549107patient 135, normal, homogenized [OPG study]6.3108863
GSM549115patient 068, normal, homogenized [OPG study]6.259462
GSM549116patient 072, normal, homogenized [OPG study]6.3567163
GSM549120patient 078, normal, homogenized [OPG study]6.1966661
GSM549131patient 030, cancer, homogenized [OPG study]7.0275171
GSM549118patient 074, normal, homogenized [OPG study]6.4033564
GSM549129patient 027, cancer, homogenized [OPG study]7.4037775
GSM549123patient 088, normal, homogenized [OPG study]5.9120857
GSM549124patient 006, cancer, homogenized [OPG study]6.8176870
GSM549126patient 015, cancer, homogenized [OPG study]6.5077965
GSM549128patient 025, cancer, homogenized [OPG study]7.3281274
GSM549103patient 117, normal, homogenized [OPG study]6.0272158
GSM549117patient 073, normal, homogenized [OPG study]6.3073663
GSM549138patient 041, cancer, homogenized [OPG study]8.28683
GSM549141patient 045, cancer, homogenized [OPG study]8.0517381
GSM549130patient 028, cancer, homogenized [OPG study]6.562366
GSM549101patient 111, normal, homogenized [OPG study]6.2256161
GSM549105patient 128, normal, homogenized [OPG study]6.2635262
GSM549106patient 134, normal, homogenized [OPG study]6.3015363
GSM549112patient 048, normal, homogenized [OPG study]6.3038463
GSM549125patient 011, cancer, homogenized [OPG study]7.2062474
GSM549127patient 024, cancer, homogenized [OPG study]6.3701563
GSM549135patient 035, cancer, homogenized [OPG study]7.8508279